10 Jun 2019
In this video, Prof. Paul Hofman outlines how his team use the Oncomine Tumor Mutation Load (TML) Assay from Thermo Fisher Scientific for benchtop next-generation sequencing (NGS) when evaluating tumour mutational burden (TMB).
Nice Sophia Antipolis University, France
Dr Paul Hofman is a Professor of Pathology at the Nice Sophia Antipolis University, France. His PhD is in Cell Biology (University of Montpellier, France) and he has been the head of the Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, University of Nice Sophia Antipolis, France, since 2003.